• Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register

SCIENTIFIC COMMITTEE

    view profile

    Yifan Li

    Shanxi Provincial Cancer Hospital, China
    view profile

    Natalia Neparidze

    Yale University, USA
    view profile

    Jagadananda Ghosh

    Henry Ford Health System, USA
    view profile

    Mohamed El-Far

    Mansoura University, Egypt

Yifan Li

Shanxi Provincial Cancer Hospital

China

Dr Li has ertise in management and passion in improving the prognosis and quality of life of patients of gastric cancer.

Member of Shanxi Anti-Cancer Association.

Natalia Neparidze

Yale University

USA

Dr. Neparidze serves as an Associate Professor and the leader of Yale Myeloma Research team. She has developed multiple research projects in myeloma, including a number of investigator-initiated therapeutic clinical trials. She serves as a PI and co-PI on multiple therapeutic clinical trials and leads several clinical outcomes studies in patients with myeloma. Her ongoing research directions include use of advanced imaging and evaluating tumor heterogeneity to enhance precision medicine approaches for myeloma, novel combination immunotherapy strategies and MRD-driven therapies in myeloma, as well as studying biology and clinical outcomes of monoclonal gammopathies in association with metabolic, viral and other co-morbidities, investigating mechanisms of tumor progression and resistance in myeloma.

Jagadananda Ghosh

Henry Ford Health System

USA

Dr. Ghosh is a Senior Scientist at the Henry Ford Hospital in Detroit, Michigan, USA. The primary focus of his research is to understand the mechanisms underlying resistance to anticancer therapies. Recently, his team made a groundbreaking observation that the Tribbles 2 pseudokinase confers resistance to anti-androgens by driving neuroendocrine trans-differentiation. He is keenly interested to explore downstream mechanisms of Tribbles 2 and develop novel agents to overcome therapeutic resistance by targeting Tribbles 2. Dr. Ghosh is an internationally renowned scientist and would like to share recent results related to mechanism-based development of a new therapy for aggressive, drug-resistant, lethal prostate cancer.

Mohamed El-Far

Mansoura University

Egypt

Professor Mohamed El-Far, worked in biochemistry field for 40 years, published over 100 peer-reviewed papers. He received Fulbright and British council fellowships several times as well as German DAAD grant to establish PDT Program at Munich, also received US-AID grant to establish PDT unit in Egypt. He is serving on the editorial boards and Hon. Editor to four international journals. He acts as UNESCO expert in science and technology. Dr. El-Far served as visiting professor to University of California as well as Utah laser center also Mayo clinic for several years. He also served as a visiting professor to Cardiff and Swansea Universities, UK. He is a member of International Photodynamic Association and Royal Society of Chemistry, UK. Selected and served as expert and consultant for biochemistry in the national committee of suprime council of Universities in Egypt, which is the highest nation honor. Selected as a member of higher Education and Research committee for Mansoura University. Selected by the International Biographical Centre, Cambridge, England to be among top 100 scientists 2012. Received honary doctorate of Letters from International Biographical Centre, Cambridge, England. Selected on the list of global speakers as chairman, a keynote speaker and honorable guest for several international conferences in cancer and diabetes as well as other recent biomedical applications as stem cells and nanotechnology. Selected as Mansoura university person of the year 2017 / 2018 and awarded certificate of recognition and Mansoura University's shield. Dr. El-Far is an international expert in photodynamic therapy (PDT), he is the first worldwide to use sildenafil as novel antiabortive agent. Dr. El-Far was selected by Royal Swedish Academy of Science to nominate Nobel Prize winners in chemistry for year 2021 which is most prestigious honor in the world.

Contact Information

+1-408-465-0048
cancercongress@innovincinternational.com
+1-408-352-1010

Locate US

5201 Great America Pkwy #320,
Santa Clara, CA 95054,
United States

Keep me Updated..!


Copyrights © 2020-21 Innovinc International, All Rights Reserved